نجاح منقطع النظير لاختبار اكتشاف وفحص السرطان سوف يتوفر قريبًا في كندا

التقارير المقدمة في الملتقى العالمي للسرطان تبين أن اختبار HAAH الخاص بشركة بانيسيا جلوبال يتسم بحساسية ودقة عالية

تورنتو – أونتاريو (Marketwire – 28 سبتمبر 2012) – (NASDAQ:PANG)(OTCBB:PANG) – في سبق جديد يحسب للقائمين على

"نجاح منقطع النظير لاختبار اكتشاف وفحص السرطان سوف يتوفر قريبًا في كندا"

Breakthrough Cancer Detection Test Could Soon Be Available in Canada

World Cancer Congress presentations show that Panacea Global’s proprietary HAAH test has high sensitivity and specificity

TORONTO, ONTARIO–(Marketwire – September 26, 2012) – (NASDAQ:PANG)(OTCBB:PANG) – Canadian healthcare providers could soon have access to a powerful …

"Breakthrough Cancer Detection Test Could Soon Be Available in Canada"

EasyMed Services Signs Nexter Group for Trial of International Medical Passport

Executives of leading defense industry player, Nexter, will benefit from having their medical records on their smartphones wherever they travel

GENEVA, SWITZERLAND–(Marketwire – Sept. 21, 2012) – EasyMed Services Inc. ® (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) (“EasyMed” or …

"EasyMed Services Signs Nexter Group for Trial of International Medical Passport"

CHMP Recommends Approval of Cialis for the Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia

AsiaNet 50754

INDIANAPOLIS, Sept. 21, 2012 /PRNewswire-AsiaNet –

– Pivotal studies support tadalafil for the treatment of benign prostatic hyperplasia and the treatment of both benign prostatic hyperplasia and erectile dysfunction in patients with both …

"CHMP Recommends Approval of Cialis for the Treatment of Signs and Symptoms of Benign Prostatic Hyperplasia"

EasyMed Reports EquityNet Research Initiates Analyst Coverage

GENEVA, SWITZERLAND–(Marketwire – Sept. 19, 2012) – EasyMed Services Inc.® (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) (“EasyMed” or the “Company”) is pleased to announce EquityNet Research, an independent equity research firm based in Los Angeles, announced on Monday, September …

"EasyMed Reports EquityNet Research Initiates Analyst Coverage"